Seeking Alpha

Is AstraZeneca weighing a bid for Forest Labs?

  • "According to usually knowledgeable people, AstraZeneca (AZN) has been running the numbers on a takeover bid for Forest Labs (FRX)," FT says.
  • AZN's advisers reportedly gained preliminary board approval for a cash offer then subsequently met with top execs at FRX, although the talks "might have already stalled following a recent surge in FRX's shares," Bryce Elder says, again citing "well-informed types."
  • Some wonder however, why FRX would have announced Project Rejuvenate if the company were planning on selling itself. "If FRX is looking to get bought, why take such a deep dive into boosting share value?" FierceBiotech's Damian Garde asks.
Comments (1)
  • Jbgoose
    , contributor
    Comments (1600) | Send Message
    Perhaps its such a mess at FRX, AZN can pull off a corporate black Friday deal. And a specialty sales force fairy dust booklet, large generic manufacturing capability? After 9% and counting laid off and debt at 7.1 ish % just to ... buy back 400 million... Strange. Smelly. Like the waterfront after a refinery blows odd colored smoke on a holiday driving on 495. Maybe they do fit.
    3 Dec 2013, 04:50 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs